North America Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Resea

North America Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Research Institutes)

The multimodal image fusion software market in North America is expected to grow from US$ 141.26 million in 2021 to US$ 235.00 million by 2028; it is estimated to reach a CAGR of 7.5% from 2021 to 2028. The diagnostic industry witnessed a huge increase in the number of diagnostic centers in the last few years because of technological and infrastructural changes in healthcare systems. Furthermore, the increasing population demands good health, which leads to a surging number of hospitals and diagnostic centers. These centers have several types of medical imaging equipment such as ultrasound, CT scans, and MRI on-site for a better diagnosis. Hospitals and diagnostics centers support doctors and physicians in providing the best care for their patients; they also help improve their fitness. Thus, hospital and diagnostics centers are a crucial part of the country’s infrastructure. Hospitals and medical centers have a wider range of diagnostic instruments on-site; and they keep upgrading themselves with the latest high-tech equipment and solutions. Due to the growing number of hospitals and testing centers, there is a rise in demand for advanced solutions and equipment for patient services. Thus, these factors are fueling the growth of the North America multimodal image fusion software market.

The North America multimodal image fusion software market, based on type, is segmented into preclinical multimodal imaging and clinical multimodal imaging. The clinical multimodal imaging segment led the market in 2020. Clinical multimodal imaging is used for the diagnosis process. The clinical multimodal imaging segment growth is driven by the rising use of high-tech products in cardiac imaging. Moreover, multimodal imaging technology integrates several imaging techniques to establish an accurate diagnosis of disease. The benefits of multimodal image fusion software have increased their use and demand in clinical trials and processes. Institutions and hospitals are significantly investing in the deployment of such software solutions to help effectively diagnose diseases. In neuroscience clinical research, multimodal imaging is being used to gain insight into the functioning and operation of the human brain. It is also used in the research & diagnosis of critical diseases, such as cancer.

North American countries increasingly adopt technologies, which also boosts the pace of development of new technologies in these countries. Rapid technological developments can also be attributed to favorable government policies to boost innovative products and reinforce infrastructure capabilities. Thus, any impact on industries directly affects the region's economic development. The US is the world's worst-affected country by the COVID-19 outbreak, thus leading to the sudden stands still across all the industries present in the region. However, the healthcare sector in many North American countries has remained unaffected during the pandemic. In addition to the rising COVID-19 cases across countries, such as the US, Canada, and Mexico, the high prevalence of other diseases has stimulated the demand for all healthcare equipment and solutions.

The overall North America multimodal image fusion software market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast of the North America multimodal image fusion software market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data and gain more analytical insights into the topic. The participants typically involved in this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the North America multimodal image fusion software market. aycan Medical Systems,LLC; Brainlab AG; Bruker Corporation; Carl Zeiss Meditec; FUJIFILM VisualSonics, Inc.; INFINITT North America Inc.; Intrasense SA; Mediso Ltd; MR Solutions Ltd.; and PerkinElmer Inc. are among the key players operating in the market in North America.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America multimodal image fusion software market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America multimodal image fusion software market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the multimodal image fusion software market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution